2020
DOI: 10.3389/fnins.2020.00675
|View full text |Cite
|
Sign up to set email alerts
|

Focused Ultrasound for Noninvasive, Focal Pharmacologic Neurointervention

Abstract: A long-standing goal of translational neuroscience is the ability to noninvasively deliver therapeutic agents to specific brain regions with high spatiotemporal resolution. Focused ultrasound (FUS) is an emerging technology that can noninvasively deliver energy up the order of 1 kW/cm 2 with millimeter and millisecond resolution to any point in the human brain with Food and Drug Administration-approved hardware. Although FUS is clinically utilized primarily for focal ablation in conditions such as essential tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 139 publications
(209 reference statements)
0
17
0
Order By: Relevance
“…The suggested approach may facilitate the development of fUS neuroimaging in any setting where dedicated hardware is not available or in clinical scanners, making this technology more affordable and opening the way to new potential applications based on this imaging modality. Additionally, sparse sequences may prove beneficial in experimental situations where fUS acquisitions need to be interleaved with long therapeutic ultrasound pulses, such as in the monitoring of focused ultrasound neurointerventions [45], [46]. Although in this study we retrospectively under-sampled the compound data, we clearly demonstrate that the network may considerably reduce the beamforming complexity and eliminate the need for computationally demanding filters [15], [16].…”
Section: Discussionmentioning
confidence: 85%
“…The suggested approach may facilitate the development of fUS neuroimaging in any setting where dedicated hardware is not available or in clinical scanners, making this technology more affordable and opening the way to new potential applications based on this imaging modality. Additionally, sparse sequences may prove beneficial in experimental situations where fUS acquisitions need to be interleaved with long therapeutic ultrasound pulses, such as in the monitoring of focused ultrasound neurointerventions [45], [46]. Although in this study we retrospectively under-sampled the compound data, we clearly demonstrate that the network may considerably reduce the beamforming complexity and eliminate the need for computationally demanding filters [15], [16].…”
Section: Discussionmentioning
confidence: 85%
“…Additionally, sparse sequences can prove beneficial in experimental situations where fUS acquisitions need to be interleaved with therapeutic ultrasound pulses, such as in the monitoring of focused ultrasound neurointerventions 40 . Importantly, this method significantly reduces the exposure time and lowers the risk of harmful bioeffects, making brain ultrasound imaging safer 3,17 .…”
Section: Discussionmentioning
confidence: 99%
“…The suggested approach can facilitate the development of fUS neuroimaging in any setting where dedicated hardware is not available or even in clinical scanners, making this technology more affordable and opening the way to new potential applications based on this imaging modality 3,39 . Additionally, sparse sequences can prove beneficial in experimental situations where fUS acquisitions need to be interleaved with therapeutic ultrasound pulses, such as in the monitoring of focused ultrasound neurointerventions 40 . Importantly, this method significantly reduces the exposure time and lowers the risk of harmful bioeffects, making brain ultrasound imaging safer 3,17 .…”
Section: Discussionmentioning
confidence: 99%
“…Through the combined use of FUS to generate oscillation openings and microbubbles—most commonly Optison, Definity, and Sonovue—to transport drugs, medications are more likely to reach their target sites in the brain and have increased efficacy [ 136 ]. Despite these potential benefits, however, it is important to note that FUS-mediated drug delivery presents certain risks that must continue to be investigated, including acute complications such as microhemorrhages and vacuolation of pericytes and other cells at the BBB following sonication, likely due to the temporary BBB disruption [ 129 , 137 ].…”
Section: Mechanisms Of Deliverymentioning
confidence: 99%